Castle Biosciences, Inc.

CSTL· NASDAQ· Health Care· Health Care Equipment & Services

$30.39+8.54%

2026-08-03

Financials

Valuation Metrics

Castle Biosciences, Inc.'s Market Cap is $922M. At end of 2025 it was $1.14B. Ranked #2539 of 3,112 in US market (top 82%), #1051 of 1,445 on NASDAQ (top 73%), #157 of 206 in Health Care Equipment & Services (top 76%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$922M	US#2,539/3,112 Sec#157/206
Revenue	$357M	US#2,478/3,112 Sec#153/206
Net Income	$-19M	US—/3,112 Sec—/206
Total Assets	$561M	US#2,702/3,112 Sec#154/206
Net Assets	$470M	US#2,299/3,112 Sec#119/206
Value
P/B	1.96x	US#1,160/3,112 Sec#66/206
P/S	2.58x	US#1,559/3,112 Sec#110/206
FCF Yield	2.24%	US#1,912/3,112 Sec#119/206
Profitability
ROE	-4.13%	US#2,294/3,112 Sec#123/206
ROA	-3.46%	US#2,460/3,112 Sec#134/206
Op. Margin	-8.13%	US#2,618/3,112 Sec#158/206
Revenue Growth	20.14%	US#738/3,112 Sec#47/206
Earnings Growth	-145.54%	US#2,165/3,112 Sec#111/206
Financial Health
Debt Ratio	19.39%	US#217/3,112 Sec#22/206
Total Debt	$37M	US#2,605/3,112 Sec#159/206
FCF	$21M	US#2,141/3,112 Sec#133/206
Cash	$62M	US#2,486/3,112 Sec#161/206
Current Ratio	6.04x	US#401/3,112 Sec#29/206
Performance
1Y Return	107.44%	US#319/3,112 Sec#28/206
1M Return	26.05%	US#71/3,112 Sec#13/206
From 52W High	-31.37%	US#2,227/3,112 Sec#153/206
1Y MDD	-57.83%	US#2,672/3,112 Sec#166/206
Trading
Volume	769,477 shares	US#1,721/3,112 Sec#127/206
Trading Value	$23M	US#1,884/3,112 Sec#129/206
Per Share
EPS	$-0.82	US—/3,112 Sec—/206
BPS	$16.05	US#1,416/3,112 Sec#83/206